Thomas Guttuso is a Neurology physician affiliated with Jacobs Institute. OpenAlex indexes 50 publications with 1,694 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 High St
Buffalo General Hospital
Buffalo, NY 142031126
Telephone
716-859-2859Registry record last updated 8 Jul 2007.
Clinical trials
- Lithium for Parkinson's: an Extension Trial
Sponsor: State University of New York at Buffalo
- Effect of Lithium Therapy on Long COVID Symptoms
Sponsor: State University of New York at Buffalo
- Amino Acid Therapy for Hot Flashes in Postmenopausal Women
Sponsor: National Center for Complementary and Integrative Health (NCCIH)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- MDD US Operations, LLCProgram year20258 payments
- Supernus Pharmaceuticals, Inc.Program year20253 payments
- UCB, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
82.5%Neuromuscular Blocker82.5%Onabotulinumtoxina100%Part B, office-administered≥16 patientsNervous system
16.4%Aromatic Amino Acid Decarboxylation Inhibitor6.7%Carbidopa-Levodopa92%Carbidopa-Levodopa Er6%Rytary1%Part D<11 patientsMonoamine Oxidase Inhibitor1.8%Rasagiline Mesylate58%Selegiline Hcl42%Part D≥22 patients+ 13 more classes in this area
Cardiovascular
0.6%Beta blocker0.4%Propranolol Hcl Er100%Part D<11 patientsalpha-Adrenergic Agonist0.2%Midodrine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2003–2017 per NIH RePORTER. The latest:
- Comparison of gabapentin and ondansetron for treating hyperemesis gravidarum
State University of New York at Buffalo
FY2017$325,742R01HD076313 - Comparison of gabapentin and ondansetron for treating hyperemesis gravidarum
State University of New York at Buffalo
FY2016$322,902R01HD076313 - Comparison of gabapentin and ondansetron for treating hyperemesis gravidarum
State University of New York at Buffalo
FY2015$317,876R01HD076313
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lithium’s effects on serum neurofilament light in Parkinson’s disease: A post hoc analysis
IBRO Neuroscience Reports
2026 - Lithium’s effects on serum neurofilament light in Parkinson’s disease: a post hoc analysis
SSRN Electronic Journal
2025 - Lithium’s effects on therapeutic targets and MRI biomarkers in Parkinson’s disease: A pilot clinical trial
IBRO Neuroscience Reports
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Lipshultz, MD
Jacobs Institute
Amit Kandel, MBBS
Jacobs Institute
Drucy Borowitz, MD
Jacobs Institute
Vanessa Barnabei, MD
Jacobs Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”